Home » Topics » BioWorld Science

BioWorld Science
RSS

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

May 3, 2022

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

May 3, 2022

Hemispherian closes seed funding to advance preclinical pipeline for cancer

May 3, 2022

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

May 3, 2022

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

May 3, 2022

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

May 3, 2022

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

May 3, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

May 3, 2022

Storm Therapeutics identifies new METTL3 inhibitors

May 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...